share_log

Neurizon Therapeutics Ltd: Positive 8-month Interim Data from OLE Study

ASX ·  Dec 15, 2024 22:34
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.